EPFB
CELG

Employees Provident Fund Board’s Celgene Corp CELG Stock Holding History

Employees Provident Fund Board’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,273,792
Closed -$81.6M – 65
2018
Q4 		$81.6M Buy
+1,273,792
New +$94M 2.28% 16
2017
Q2 		– Sell
-411,143
Closed -$51.2M – 55
2017
Q1 		$51.2M Sell
411,143
-4,272
-1% -$511K 1.49% 26
2016
Q4 		$48.1M Buy
415,415
+166,349
+67% +$18.5M 1.65% 27
2016
Q3 		$26M Buy
+249,066
New +$27M 0.93% 33

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Employees Provident Fund Board's CELG Position: Q1 2019 in Review

Employees Provident Fund Board sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 1,273,792 shares — an estimated $81.6M sold.

Employees Provident Fund Board first reported a position in CELG in Q3 2016 and held it in 4 quarters. The position peaked at $81.6M in Q4 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Employees Provident Fund Board reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Employees Provident Fund Board sold 1,273,792 Celgene Corp shares in Q1 2019, an estimated $81.6M.
  • Employees Provident Fund Board first reported a position in Celgene Corp in Q3 2016 and held it in 4 quarters.
  • Employees Provident Fund Board's Celgene Corp position peaked at $81.6M in Q4 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Employees Provident Fund Board's 13F filing for Q1 2019, filed 18 Mar 2026.